These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 14585520)

  • 21. Estradiol pharmacokinetics after transdermal application of patches to postmenopausal women: matrix versus reservoir patches.
    Reginster JY; Donazzolo Y; Brion N; Lins R
    Climacteric; 2000 Sep; 3(3):168-75. PubMed ID: 11910618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative serum estradiol profiles from a new once-a-week transdermal estradiol patch and a twice-a-week transdermal estradiol patch.
    Harrison LI; Riedel DJ; Chang SF; Jacobson JP; Sellers JA; Kanniainen CM; Crowley JK; Hinderling PH
    Ther Drug Monit; 1997 Feb; 19(1):37-42. PubMed ID: 9029744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of pharmacokinetic profiles of a 17 beta-estradiol gel 0.6 mg/g (Gelestra) with a transdermal delivery system (Estraderm TTS 50) in postmenopausal women at steady state.
    Paoletti AM; Pilia I; Nannipieri F; Bigini C; Melis GB
    Maturitas; 2001 Dec; 40(3):203-9. PubMed ID: 11731181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of a 7-day 17 beta-estradiol transdermal delivery system: effect of application site and repeated applications on serum concentrations of estradiol and estrone.
    Boyd RA; Yang BB; Abel RB; Eldon MA; Sedman AJ; Forgue ST
    J Clin Pharmacol; 1996 Nov; 36(11):998-1005. PubMed ID: 8973988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New trends in transdermal technologies: development of the skin patch, Menorest.
    Marty JP
    Int J Gynaecol Obstet; 1996 Mar; 52 Suppl 1():S17-20. PubMed ID: 8666122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum concentrations of 17beta-estradiol and estrone after multiple-dose administration of percutaneous estradiol gel in symptomatic menopausal women.
    Brennan JJ; Lu Z; Whitman M; Stafiniak P; van der Hoop RG
    Ther Drug Monit; 2001 Apr; 23(2):134-8. PubMed ID: 11294513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bioavailability of 17 beta-estradiol after transdermal administration--dependence on the patch system].
    Schmolling J; Kusche J; van der Ven H; Schander K
    Zentralbl Gynakol; 1998; 120(3):121-5. PubMed ID: 9556902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug concentration effect relationship of estradiol from two matrix transdermal delivery systems: Menorest and Climara.
    Andersson TL; Stehle B; Davidsson B; Höglund P
    Maturitas; 2000 Jun; 35(3):245-52. PubMed ID: 10936741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and tolerability of Menorest 50 compared with Estraderm TTS 50 in the treatment of postmenopausal symptoms. A randomized, multicenter, parallel group study.
    Pornel B; Genazzani AR; Costes D; Dain MP; Lelann L; Vandepol C
    Maturitas; 1995 Nov; 22(3):207-18. PubMed ID: 8746878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioavailability of estradiol from two matrix transdermal delivery systems: Menorest and Climara.
    Andersson TL; Stehle B; Davidsson B; Höglund P
    Maturitas; 2000 Jan; 34(1):57-64. PubMed ID: 10687883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
    Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
    Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Steady-state bioavailability of estradiol from two matrix transdermal delivery systems, Alora and Climara.
    Buch A; Shen L; Kelly S; Sahota R; Brezovic C; Bixler C; Powell J
    Menopause; 1998; 5(2):107-12. PubMed ID: 9689205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of dose on the absorption of estradiol from a transdermal gel.
    Järvinen A; Granander M; Laine T; Viitanen A
    Maturitas; 2000 Apr; 35(1):51-6. PubMed ID: 10802400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of site of application on the transcutaneous absorption of 17-beta estradiol from a transdermal delivery system (Climara).
    Taggart W; Dandekar K; Ellman H; Notelovitz M
    Menopause; 2000; 7(5):364-9. PubMed ID: 10993035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic comparison of two nicotine transdermal systems, a 21-mg/24-hour patch and a 25-mg/16-hour patch: a randomized, open-label, single-dose, two-way crossover study in adult smokers.
    DeVeaugh-Geiss AM; Chen LH; Kotler ML; Ramsay LR; Durcan MJ
    Clin Ther; 2010 Jun; 32(6):1140-8. PubMed ID: 20637967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma estradiol concentrations and pharmacokinetics following transdermal application of Menorest 50 or Systen (Evorel) 50.
    Reginster JY; Albert A; Deroisy R; Colette J; Vrijens B; Blacker C; Brion N; Caulin F; Mayolle C; Regnard A; Scholler R; Franchimont P
    Maturitas; 1997 Jun; 27(2):179-86. PubMed ID: 9255753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioavailability of estradiol from a new matrix and a conventional reservoir-type transdermal therapeutic system.
    Müller P; Botta L; Ezzet F
    Eur J Clin Pharmacol; 1996; 51(3-4):327-30. PubMed ID: 9010707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous estradiol and levonorgestrel transdermal delivery from a 7-day patch: in vitro and in vivo drug deliveries of three formulations.
    Harrison LI; Zurth C; Gunther C; Karara AH; Melikian A; Lipp R
    Drug Dev Ind Pharm; 2007 Apr; 33(4):373-80. PubMed ID: 17523002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the pharmacokinetics of 17 beta-estradiol after a single 4-day application of Oesclim 50, Oesclim 100, and Vivelle 0.05 (Menorest 50) transdermal delivery systems.
    Guichard JP; Sauron R; Jones AB
    J Clin Pharmacol; 1999 Aug; 39(8):811-6. PubMed ID: 10434233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Half-life of estradiol in postmenopausal women.
    Ginsburg ES; Gao X; Shea BF; Barbieri RL
    Gynecol Obstet Invest; 1998; 45(1):45-8. PubMed ID: 9473164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.